Insider Selling: Stryker (NYSE:SYK) Insider Sells 826 Shares

Key Points

• Stryker insider Debra King sold 826 shares for approximately $277,784, reducing her direct holdings by 11.74% to 6,210 shares.
• Stryker shares rose 0.1% to $331.96, while the company reported quarterly EPS of $3.69 and revenue of $6.59 billion, both slightly exceeding analyst expectations.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and average price target of $386.28; institutional investors own 77.09% of the stock.

Stryker Corporation (NYSE:SYK - Get Free Report) insider Debra King sold 826 shares of Stryker stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Stryker Stock Up 0.1%

Shares of Stryker stock traded up $0.28 during trading hours on Tuesday, hitting $331.96. 3,179,813 shares of the company's stock traded hands, compared to its average volume of 2,370,435. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The company has a market cap of $127.33 billion, a PE ratio of 34.40, a PEG ratio of 2.16 and a beta of 0.76. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a 50 day simple moving average of $325.21 and a 200-day simple moving average of $333.24.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. The firm had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker's revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio is presently 36.48%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SYK. BMO Capital Markets began coverage on shares of Stryker in a research note on Wednesday, July 8th. They set an "outperform" rating and a $369.00 price objective on the stock. Truist Financial raised their price objective on shares of Stryker from $330.00 to $340.00 and gave the company a "hold" rating in a research report on Friday, July 31st. Piper Sandler dropped their target price on shares of Stryker from $420.00 to $390.00 and set an "overweight" rating on the stock in a report on Friday, July 31st. Raymond James Financial set a $370.00 target price on shares of Stryker in a research note on Friday, July 31st. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Stryker in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Stryker presently has a consensus rating of "Moderate Buy" and an average price target of $386.28.

Institutional Trading of Stryker

Hedge funds have recently made changes to their positions in the stock. Norges Bank bought a new stake in Stryker in the fourth quarter worth approximately $1,822,272,000. Bank of America Corp DE bought a new stake in Stryker in the second quarter worth $1,404,284,000. Auto Owners Insurance Co increased its position in Stryker by 35,047.0% during the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company's stock worth $1,024,444,000 after buying an additional 2,906,448 shares during the last quarter. Legal & General Group Plc bought a new position in Stryker during the second quarter valued at about $707,212,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Stryker in the second quarter worth about $681,581,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source